Published on : Jun 21, 2016
ALBANY, New York, June 21, 2016: A new market study, titled “Research Report on Hemodialysis Industry in China, 2011-2020,” has been featured on ResearchMoz.us. The research report is a professional effort to understand the progression of the global hemodialysis industry, with a special focus on the China industry. The various factors that will define trends in the global and China market for hemodialysis in the future are analyzed in this report. The report also presents a detailed outlook of the current market landscape and growth prospects of the China hemodialysis industry between 2011 and 2020.
The report analyzes the China hemodialysis market from a competitive perspective. The top companies actively involved in the China hemodialysis market are mentioned and a detailed competitive profile presented for each of them. These are Fresenius Medical Care, Baxter International Inc., Shandong Weigao Group Medical Polymer Co. Ltd., Jihua Medical Apparatus & Instruments Co. Ltd, Guangdong Biolight Meditech Co. Ltd., Zhuhai Hokai Medical Instruments Co. Ltd., NIPRO Medical Corporation, Asahi Kasei Medical Co. Ltd., SWS Hemodialysis Care Co. Ltd., Sichuan Kelun Pharmaceutical Co. Ltd., and Bain Medical Equipment Co. Ltd. Details pertaining to business positioning, product portfolio, and recent developments are provided for each of the companies.
Hemodialysis (HD) is one of the renal replacement therapies to treat severe or chronic renal failure conditions. Presently, more than 2 million people suffer from end-stage renal disease (ESRD) across the globe and have undertaken dialysis therapy for the same. Out of this, 90% receive hemodialysis as a course of treatment for the condition.
Click here to get more info with TOC in a PDF Format: https://www.researchmoz.us/enquiry.php?type=S&repid=729035
The report presents some key findings of the statistics of dialysis therapy worldwide. The concentration of dialysis patients is predominantly in developed countries due to the high expense of the treatment. This is explained by the fact that only 10%-20% ESRD patients in developing countries undergo dialysis treatment as opposed to 80% patients in developed countries. However, the number of patients undergoing dialysis is growing fast in developing countries as well. Recent studies have recorded the annual growth rate of dialysis patients as more than 10% in India, China, and Brazil. This is much higher than the 3%-5% growth rate of dialysis patients in developed countries in the recent past.
The report states that the China hemodialysis market has immense growth potential. The increasing population of ESRD patients in the country, of which only a small proportion can afford dialysis therapy, presents growth opportunities for the market. For example, in 2015, more than 2 million patients suffered from ESRD in China of which only 300,000 patients could receive dialysis therapy. The improvement of healthcare in China and the increasing number of ESRD patients who can afford hemodialysis will lead to the rapid expansion of the hemodialysis industry in China, adds the report.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on [email protected]